A Phase II Study of VELCADE TM(PS-341) and Irinotecan in the Treatment of Progressive, Recurrent or Metastatic Cervical, Vulvar, or Vaginal Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2007
At a glance
- Drugs Bortezomib; Irinotecan
- Indications Cervical cancer
- Focus Therapeutic Use
- 16 Aug 2005 New trial record.